Alnylam PharmaceuticalsALNY 
$265.271.35%24h
1.35%24h
Global rank542
Market cap$33.13B
Change 7d7.55%
YTD Performance39.70%
SP500 benchmarkOutperform
P/E-75.36
P/S18.12
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals ALNY Operating Margins
Operating Margin in 2022: -0.15%
According to Alnylam Pharmaceuticals latest financial reports the company has an operating margin of -0.15%, an decrease of -79.61% to 2022. At the end of 2022 company had an operating margin of -0.76%.
Alnylam Pharmaceuticals Operating Margin from 2020 to 2024
-
Value:-
ALNY Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -0.15% | -79.61% |
| 2022 | -0.76% | -9.84% |
| 2021 | -0.84% | -50.07% |
| 2020 | -1.68% | - |
View the highest operating margin companies 
